David Planchard, Thoracic Oncologist, Professor at University Paris Saclay and Head of Thoracic Cancer Group at Gustave Roussy, shared a post on LinkedIn:
“A pleasure to have shared the podium in Cannes with Pr P.Hofman to discuss diagnostic and therapeutic advances in EGFR lung patients….important role of combination with chemotherapy (brain mets, high tumor burden, ctDNA, L858R…), TKIs and ADCs coming…”
More posts featuring David Planchard.
